Chapter 3C Specialty Nursing Competencies Kookaburra Ward

Size: px
Start display at page:

Download "Chapter 3C Specialty Nursing Competencies Kookaburra Ward"

Transcription

1 Chapter 3C pecialty Nursing Competencies ookaburra Ward Nursing Competency Workbook, 7th Edition RCH Nursing Competency Workbook Chapter 3 Page 1

2 The Royal Children's Hospital (RCH) Nursing Competency Workbook is a dynamic document that will provide you with direction and assist you in your professional development as a nurse working at the RCH. The workbook also provides a record of your orientation and competency obtainment. Chapter 1 Includes resources for nurses and is complemented by the Royal Children s Hospital (RCH) New tarter Pack, Hospital Orientation and Nursing Orientation day, to provide an introduction to nursing at the RCH. Chapter 2 Generic Nursing Competency Assessment Forms Chapter 3 pecialty Nursing Competency Assessment Forms Appendix 1 Unit / Department Nursing Orientation All chapters and appendices are downloadable as pdfs from the Nursing Education Website. The RCH Nursing Competency Workbook developed by Nursing Education with input from specialist nurses at the RCH. For further information contact: Melody Trueman Director, Nursing Education T: (03) E: melody.trueman@rch.org.au Workbook Edition 7, January 2015 RCH Nursing Competency Workbook Chapter 3

3 Table of Contents Blood ampling from Central Venous Access Devices 1 Bone marrow aspirates and Lumbar Punctures (Oncology) 2 Chemotherapy (intramuscular administration) 3 Chemotherapy (intrathecal administration) 4 Chemotherapy (intravenous infusion) 5 Chemotherapy (intravenous push) 6 Chemotherapy (Management & upportive Care Theory) 7 Chemotherapy (oral administration) 8 Chemotherapy (afe handling) 9 Chemotherapy (subcutaneous administration) 10 Central Venous Access Device (Blocked) 11 Criteria Led Discharge (put in generic competency?) 12 Febrile Neutropenia 13 Hickman Catheter Removal 14 Infusion of Cryopreserved Haemopoietic Progenitor Cells (HPC) - Oncology 15 Infusion of Fresh Haemopoietic Progenitor Cells (HPC) - Oncology 16 Mucositis (Oncology) 17 Nutrition (Parenteral) 18 Pain (Analgesia Infusion) 19 Pain (Patient Controlled Analgesia) 20 Potassium Infusion (oncology) 21 Procedural edation nitrous oxide accreditation skill 22 Procedural edation nitrous oxide theory 23 ubcutaneous Catheter devices management (Infusion and BD at-t-intima ) 24 Competency Feedback & Reflection 25 RCH Nursing Competency Workbook Chapter 3

4 Blood ampling from Central Venous Access Devices ALERT: The Central Venous Access Device Management Competency should be completed prior to or in conjunction with this competency Competency tatement: The nurse can safely and effectively collect a blood sample from a central Venous Access Device (CVAD) 1. Describe the circumstances when bloods might need to be taken from a CVAD 2. Identify a. blood tests frequently taken from CVADs b. tubes required for tests identified above c. volumes required 3. Discuss when gloves would be worn for blood sampling from CVADs and why 4. Discuss safe handling procedures of blood specimens 5. Discuss the correct size syringe to take blood from a CVAD 6. Discuss, with regards to discarding blood: a. When a volume of blood should be discarded prior to the blood specimen being collected and why b. How much blood should be discarded c. In what circumstances a discard sample would be returned to the patient 1. Demonstrate education of the patient / family / carer regarding blood collection from a CVAD 2. Assemble correct equipment for the collecting a blood specimen from a CVAD 3. Demonstrate the procedure for taking blood from a single lumen CVAD 4. Demonstrate the procedure for taking blood from a multi lumen CVAD 5. Demonstrate correct labelling of blood specimens 6. Demonstrate correct completion of pathology forms RCH Nursing Competency Workbook Chapter 3 Page 1

5 Bone marrow aspirates and Lumbar Punctures (Oncology) Competency tatement: The nurse will safely and effectively care for a child with cancer requiring a bone marrow aspirate or lumbar puncture 1. Define: a. Bone Marrow Aspirate (BMA) b. Lumbar Puncture (LP) 2. Discuss the reasons for BMA and LP being performed on children with cancer 3. Discuss pre BMA and LP blood tests and range required in order for BMA or LP to proceed 4. tate potential complications and management of: a. BMA b. LP 5. Discuss required observations of patients post BMA or LP 6. Outline key considerations in the Intrathecal administration of drugs 1. Demonstrate location of most common site chosen for performing BMA and LP, including application of local anaesthetic cream 2. Demonstrate preparation of the patient for a a. BMA b. LP 3. Demonstrate education of the family regarding BMA and LP RCH Nursing Competency Workbook Chapter 3 Page 2

6 Chemotherapy (intramuscular administration) ALERT: The nurse must have completed the medication administration, Chemotherapy (management supportive care theory) and Chemotherapy (safe handling) competencies prior to completion of this competency Competency tatement: The nurse will safely and effectively administer chemotherapy via intramuscular injection RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. tate the child s diagnosis and treatment protocol 3. Identify the cytotoxic agents to be administered 4. Outline the pre- chemotherapy investigations required for the particular cytotoxic agents being administered 5. Recall potential side effects and management of the cytotoxic agents being administered 6. Discuss antiemetic coverage required for cytotoxic agent being administered 7. Discuss principles of administration of cytotoxic agent via intramuscular injection 8. Outline necessary monitoring of patient during / following administration of cytotoxic agents via intramuscular injection 1. Establish a safe work environment 2. Demonstrate correct process to confirm accuracy of order 3. Demonstrate application of principles of safe handling in administration of cytotoxic agent via intramuscular injection 4. Demonstrate safe disposal of equipment used in administration of a cytotoxic agent via intramuscular injection RCH Nursing Competency Workbook Chapter 3 Page 3

7 Chemotherapy (intrathecal administration) ALERT: The nurse must have completed the medication administration, Chemotherapy (management supportive care theory) and Chemotherapy (safe handling) competencies prior to completion of this competency Competency tatement: The nurse safely and effectively assists in the administration of intrathecal chemotherapy RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. tate the child s diagnosis and treatment protocol 3. List the drugs that are administered intrathecally in the treatment of cancer 4. Discuss the dose calculation for cytotixic agents administered intrathecally 5. Identify the cytotoxic agents to be administered? 6. Outline the pre- chemotherapy investigations required for the particular cytotoxic agents being administered 7. Recall potential side effects and management of the cytotoxic agents being administered 8. Discuss antiemetic coverage required for cytotoxic agent being administered 9. Discuss principles of administration of intrathecal cytotoxic agent 10. Outline necessary monitoring of patient during / following administration of intrathecal cytotoxic agents 1. Establish a safe work environment 2. Demonstrate correct process to confirm accuracy of order 3. Demonstrate application of principles of safe handling in assisting in the administration of intrathecal cytotoxic agent 4. Demonstrate safe disposal of equipment used in administration of an IV push of a cytotoxic agent RCH Nursing Competency Workbook Chapter 3 Page 4

8 Chemotherapy (intravenous infusion) ALERT: The nurse must have completed the medication administration, intravenous cannula management (peripheral), CVAD management, Chemotherapy (management supportive care theory) and Chemotherapy (safe handling) competencies prior to completion of this competency Competency tatement: The nurse will safely and effectively administer chemotherapy via intravenous infusion RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. tate the child s diagnosis and treatment protocol 3. Identify the cytotoxic agents to be administered? 4. Outline the pre- chemotherapy investigations required for the particular cytotoxic agents being administered 5. Recall potential side effects and management of the cytotoxic agents being administered 6. Discuss antiemetic coverage required for cytotoxic agent being administered 7. Discuss principles of administration of cytotoxic agents via IV infusion 8. Identify classification of cytotoxic agents being administered as non irritants, irritants or vesicants 9. Discuss management of cytotoxic drug extravasation 10. Outline necessary monitoring of patient during / following administration of cytotoxic agents via IV infusion 1. Establish a safe work environment 2. Demonstrate correct process to confirm accuracy of order 3. Demonstrate application of principles of safe handling in administration of cytotoxic agent via IV infusion 4. Demonstrate safe administration of an irritant or a vesicant agent as an IV infusion 5. Demonstrate safe disposal of equipment used in administration of an IV push of a cytotoxic agent RCH Nursing Competency Workbook Chapter 3 Page 5

9 Chemotherapy (intravenous push) ALERT: The nurse must have completed the medication administration, intravenous cannula management (peripheral), CVAD management, Chemotherapy (management supportive care theory) and Chemotherapy (safe handling) competencies prior to completion of this competency Competency tatement: The nurse will safely and effectively administer chemotherapy via intravenous push RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. tate the child s diagnosis and treatment protocol 3. Identify the cytotoxic agents to be administered 4. Outline the pre chemotherapy investigations required for the particular cytotoxic agents being administered 5. Recall potential side effects and management of the cytotoxic agents being administered 6. Discuss antiemetic coverage required for cytotoxic agent being administered 7. Discuss principles of administration of cytotoxic agent via IV push 8. Identify classification of cytotoxic agents being administered as non irritant, irritant or vesicant 9. Discuss management of cytotoxic drug extravasation 10. Outline necessary monitoring of patient during / following administration of cytotoxic agents via IV push 1. Establish a safe work environment 2. Demonstrate correct process to confirm accuracy of order 3. Demonstrate application of principles of safe handling in administration of cytotoxic agent via IV push 4. Demonstrate safe administration of an irritant or a vesicant agent as an IV push 5. Demonstrate safe disposal of equipment used in administration of an IV push of a cytotoxic agent RCH Nursing Competency Workbook Chapter 3 Page 6

10 Chemotherapy (Management & upportive Care Theory) ALERT: This competency is required for all nurses who care for a child receiving or who has received chemotherapy Competency tatement: The nurse has the requisite knowledge to provide supportive care to a patient receiving cytotoxic therapy. RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. Identify resources available to access for information regarding cytotoxic agents (drug information and supportive care) 3. Describe the key elements of the chemotherapy protocol (MR 53B) 4. Outline the pre chemotherapy investigations required 5. Discuss side effects of administered cytotoxic agents 6. Outline management for potential immediate side effects 7. ummarise antiemetic options for the patient receiving cytotoxic agents. 8. Discuss nursing precautions, care and monitoring for a patient receiving chemotherapy including a. monitoring of urine output b. pre and post hydration c. line set up d. observations e. other medications (e.g. mesna, folinic acid) 9. Identify relevant tests patient may require whilst receiving cytotoxic agents 10. Discuss the management of cytotoxic drug extravasation 11. ummarise family understanding of treatment being delivered and areas for education Not Applicable RCH Nursing Competency Workbook Chapter 3 Page 7

11 Chemotherapy (oral administration) ALERT: The nurse must have completed the medication administration, Chemotherapy (management supportive care theory) and Chemotherapy (safe handling) competencies prior to completion of this competency Competency tatement: The nurse will safely and effectively administer oral chemotherapy RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. tate the child s diagnosis and treatment protocol 3. Identify the oral cytotoxic agents to be administered? 4. Outline the pre chemotherapy investigations required for the particular cytotoxic agents being administered 5. Recall potential side effects and management of the cytotoxic agents being administered 6. Discuss antiemetic coverage required for cytotoxic agent being administered 7. Discuss principles of administration of oral cytotoxic agents 8. Outlines necessary monitoring of patient during / following administration of oral cytotoxic agents 9. Establish a safe work environment 10. Demonstrate correct process to confirm accuracy of order 11. Demonstrate application of principles of safe handling in administration of oral cytotoxic agents 12. Demonstrate safe disposal of equipment used in administration of oral cytotoxic agents RCH Nursing Competency Workbook Chapter 3 Page 8

12 Chemotherapy (afe handling) ALERT: This competency is required for all nurses who care for a child receiving or who has received chemotherapy Competency tatement: The nurse safely and effectively handles cytotoxic agents and disposes of cytotoxic waste. RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. Discuss safe transport and storage of cytotoxic agents from pharmacy to patient 3. Demonstrate set up of a safe working environment 4. Discuss correct use of personal protective equipment (PPE) required to a. administer cytotoxic agents b. dispose of cytotoxic waste i. equipment ii. excess cytotoxic agents iii. contaminated lined and clothing iv. patients personal waste (vomit, urine, faeces and blood) 5. tate action required if personal contamination with a cytotoxic agent occurs 6. Outline correct procedure to manage a cytotoxic spill 7. Discuss safe management/disposal of cytotoxic waste a. equipment b. excess cytotoxic agents c. contaminated linen and clothing d. patients personal waste (vomit, urine, faeces and blood) 8. ummarise information provided to children and families in regards to safe handling, including resources available Not Applicable RCH Nursing Competency Workbook Chapter 3 Page 9

13 Chemotherapy (subcutaneous administration) ALERT: The nurse must have completed the medication administration, Chemotherapy (management supportive care theory) and Chemotherapy (safe handling) competencies prior to completion of this competency Competency tatement: The nurse will safely and effectively administer chemotherapy via subcutaneous injection RCH References: RCH Intranet Clinical Management Guidelines: Cytoxic drugs The management of 1. Locate and read the references related to this competency 2. tate the child s diagnosis and treatment protocol 3. Identify the cytotoxic agents to be administered? 4. Outline the pre- chemotherapy investigations required for the particular cytotoxic agents being administered 5. Recall potential side effects and management of the cytotoxic agents being administered 6. Discuss antiemetic coverage required for cytotoxic agent being administered 7. Discuss principles of administration of cytotoxic agent via subcutaneous injection 8. Outline necessary monitoring of patient during / following administration of cytotoxic agents via subcutaneous injection 9. Discuss the use and management of Insuflons in the administration subcutaneous cytotoxic agents 1. Establish a safe work environment 2. Demonstrate correct process to confirm accuracy of order Demonstrate application of principles of safe handling in administration of cytotoxic agent via subcutaneous injection 3. Demonstrate safe disposal of equipment used in administration of a subcutaneous injection of a cytotoxic agent RCH Nursing Competency Workbook Chapter 3 Page 10

14 Central Venous Access Device (Blocked) ALERT: The Central Venous Access Device Management Competency should be completed prior to this competency Competency tatement: The nurse can safely attempt to unblock a central venous access device (CVAD) RCH References: RCH Intranet Clinical Management Guidelines: Anticoagulation Therapy 1. Locate and read the references related to this competency 2. List possible causes of CVAD occlusion 3. Discuss CVAD management to minimise the risk of occlusion 4. Describe a Fibrin heath? 5. Discuss rationale for syringe size selection in flushing CVADs 6. Discuss the steps to be taken in attempting to unblock a CVAD that has a. A blood related blockage b. A chemical related blockage 7. tate the length of time TPA should be left in the line 8. tate the documentation / communication required to alert others that TPA is in the line 9. Describe the potential side effects of TPA and HCl 10. Discuss management of a blocked CVAD in which initial attempts to clear the blockage have failed Not Applicable RCH Nursing Competency Workbook Chapter 3 Page 11

15 Criteria Led Discharge Competency tatement: The nurse safely and effectively discharges a child applying criteria led discharge process RCH References: RCH Policies & Procedures: Criteria Led Discharge 1. Locate and read the references related to this competency 2. Discuss the benefits of criteria led discharge (clinical practices guidelines) a. For the family b. For the organisation 3. Discuss the expectations of nursing staff within the criteria led discharge process 4. Discuss the required authorization from medical staff for criteria led discharge to occur and identify where this particular information is documented 5. Discuss the medical review requirements for a child who will have a criteria led discharge 6. Highlight some of the issues that may need addressing when discharging a patient via a criteria led discharge order 7. Discuss the discharge follow up required and how this is arranged 1. Demonstrate discussion with the family explaining the criteria led discharge process RCH Nursing Competency Workbook Chapter 3 Page 12

16 Febrile Neutropenia Competency tatement: The nurse will safely and effectively care for a patient with Febrile Neutropenia RCH References: RCH Intranet Clinical Management Guidelines: Febrile Neutropenia; epsis Assessment & Management 1. Locate and read the references related to this competency 2. tate the normal values a. Haemoglobin b. Platelets c. White Blood count d. Neutrophils 3. Describe the function of neutrophils 4. Define the term febrile neutropenia 5. Discuss the observations required during an admission for neutropenia 6. Discuss the actions to be taken where observations are outside the normal range for the child s age 7. Discuss the use of paracetamol and Ibuprofen in the care of children who have febrile neutropenia 8. Explain the rationale for the following investigations as part of a septic work up a. Blood cultures b. wabs nose / throat / CVAD c. Urine d. tool 9. Explain which blood cultures need to be taken and how much blood you would take for a child weighing 20kg 10. Discuss CVAD line set up for administration of antibiotics for the child with febrile neutropenia 11. Discuss the management of suspected febrile neutropenia on presentation to emergency 12. Discuss the management provided in the first 72 hours of admission for febrile neutropenia 13. tate the antibiotics and dosages used as first line treatment for febrile neutropenia. 14. tate the expected timeframe that the first dose of antibiotics should be given, and why 15. Discuss treatment options for patients with unresolved fever 16. tate the signs and symptoms of septic shock 17. Identify potential sources/portals/causes of infection in patients with neutropenia and discuss ways to minimise the risk 18. List ways in which staff/parents and children can help prevent infection 1. Discuss and demonstrate collection of blood cultures from a Central Venous Access Device 2. Demonstrate education of children and families about neutropenia and describe the key points that you would educate a family about febrile neutropenia. RCH Nursing Competency Workbook Chapter 3 Page 13

17 Hickman Catheter Removal Competency tatement: The nurse safely and effectively removes a Hickman Catheter 1. Discuss reasons for Hickman Catheter removal 2. Discuss strategies to minimise pain and distress during Hickman Catheter removal 3. Describe the steps in removing a Hickman Catheter a. sterile field b. Location of cuff c. Removal of stitches (if applicable) d. Pulling on Hickman catheter e. Pressure to neck scar f. Dressing 4. Describe observation and monitoring of patient post removal of Hickman Catheter 5. Discuss the education required by the family prior to discharge 1. Demonstrate preparation of the child and family for the removal of a Hickman Catheter a. Explanation of i. reason for removal ii. the process of removal iii. post removal care, b. Assemble required equipment c. Revise results of investigations to ascertain findings are within range for Hickman Catheter removal 2. Demonstrate removal of a Hickman Catheter RCH Nursing Competency Workbook Chapter 3 Page 14

18 Infusion of Cryopreserved Haemopoietic Progenitor Cells (HPC) - Oncology ALERT: The nurse must have completed the CVAD Management competency prior to completion of this competency Competency tatement: The nurse will safely and effectively administer cryopreserved haemopoietic progenitor cells (HPC) via intravenous infusion. RCH References: RCH Intranet Children s Cancer Centre - Haematopoietic tem Cell Transplant (HCT) Program Documents: Infusion of Cryopreserved Haemopoietic Progenitor Cells Clinical Work Instruction CL-W-001; Transplantation of Cryopreserved Haemopoietic Progenitor Cells Clinical Procedure CL-P-001; Adverse Reactions Associated with Haemopoietic Progenitor Cell Infusion Clinical Work Instruction CL-W Locate and read references related to this competency 2. Discuss the actions required the day prior to and the morning of the cryopreserved HPC infusion including a. Communication with the laboratory b. Orders required for premedication, IV hydration and cryopreserved HPC product 3. Identify premedications required prior to infusion of cryopreserved HPC and administer as prescribed 4. Identify hydration fluids required prior to and after infusion of a cryopreserved HPC product and administer as prescribed 5. Discuss the nursing care required post the HPC infusion 6. Outline 7. urine testing & output 8. monitoring for delayed reactions 9. Discuss the adverse reactions associated with HPC infusion and identify the documentation and actions required for a a. mild reaction b. moderate to severe reaction c. late reaction 10. Outline the education required for the patient and family undergoing a cryopreserved HPC transplantation 1. Demonstrate correct set up of IV lines and outline a. line/syringe required for HPC infusion (do not prime with HPC product) b. additional Normal aline line 2. Demonstrate the patient monitoring required prior, during and post the cryopreserved HPC infusion (including presence of medical staff) 3. Perform patient ID and HPC product checks according to clinical procedure 4. Demonstrate the correct procedure for administrating a cryopreserved HPC product via a. an IV line b. a syringe and outline a. blood filter to be used b. fluids that may run with HPC infusion c. amount of HPC product to infuse initially d. wait time required before proceeding with rest of HPC infusion (restart IV fluids to prevent blockage) e. recommended infusion times of HPC RCH Nursing Competency Workbook Chapter 3 Page 15

19 Infusion of Fresh Haemopoietic Progenitor Cells (HPC) - Oncology ALERT: The nurse must have completed the CVAD Management competency prior to completion of this competency Competency tatement: The nurse will safely and effectively administer fresh haematopoietic progenitor cells (HPC) via intravenous infusion RCH References: RCH Intranet Children s Cancer Centre - Haematopoietic tem Cell Transplant (HCT) Program Documents: Infusion of Fresh Haemopoietic Progenitor Cells Clinical Work Instruction CL-W-002; Transplantation of Fresh Haemopoietic Progenitor Cells Clinical Procedure CL-P-002; Adverse Reactions Associated with Haemopoietic Progenitor Cell Infusion Clinical Work Instruction CL-W Locate and read references related to this competency 2. Discuss the actions required the day prior to and the morning of the fresh HPC infusion including a. Communication with the laboratory (& valid recipient specimen) b. Orders required for premedication, IV hydration and fresh HPC product 3. Identify premedications required prior to infusion of fresh HPC and administer as prescribed for a. ABO identical or group compatible HPC product b. Minor ABO mismatch HPC product c. Major ABO mismatch HPC product 4. Identify hydration fluids required prior to and after infusion of a fresh HPC product and administer as prescribed for a. ABO identical or group compatible HPC product b. Minor ABO mismatch HPC product c. Major ABO mismatch HPC product 5. Discuss the nursing care required post the fresh HPC infusion and outline a. urine testing & output b. monitoring for delayed reactions 6. Discuss the adverse reactions associated with fresh HPC infusion and identify the documentation and actions required for a a. mild reaction b. moderate to severe reaction c. late reaction 7. Outline the education required for the patient and family undergoing a fresh HPC transplantation 1. Demonstrate correct set up of IV lines and outline a. Line/syringe required for HPC infusion (do not prime with HPC product) b. Additional Normal aline line 2. Demonstrate the patient monitoring required prior, during and post the fresh HPC infusion (including presence of medical staff) for a. ABO identical or group compatible HPC product b. Minor ABO mismatch HPC product c. Major ABO mismatch HPC product 3. Perform patient ID, donor ID and HPC product checks according to clinical procedure 4. Demonstrate the correct procedure and infusion rate for administrating a fresh HPC product via an IV line and outline: a. blood filter to be used b. fluids that may run with HPC infusion c. infusion rate at commencement of HPC infusion d. recommended infusion times of HPC product & use of frusemid RCH Nursing Competency Workbook Chapter 3 Page 16

20 Mucositis (Oncology) Competency tatement: The nurse safely and effectively cares for a child with cancer at risk of or with mucositis RCH References: RCH Clinical Practice Guidelines: Mouth Care Oral Care of the paediatric oncology patient and haematopoietic stem cell transplant patient; Perianal care for the paediatric oncology patient 1. Locate and read the following clinical practice guidelines a. oral hygiene for haematology oncology children b. perianal care for the paediatric oncology patient 2. Define Mucositis 3. Discuss potential causes of Mucositis for children with cancer 4. Discuss the signs and symptoms the patient may present with when experiencing mucositis 5. Discuss the Oral Assessment Guide score 6. Discuss oral hygiene measures to reduce the risk of oral mucositis 7. Discuss management to reduce the risk of perianal mucositis 8. Discuss the management of a patient with mucositis a. Oral b. Gastrointesitinal c. Perineal d. Pain relief 9. Discuss the link between recovering neutrophil count and resolution of mucositis 1. Demonstrate assessment of a patient s mouth and accurate documentation of results 2. Demonstrate assessment of a patient s perineum and accurate documentation of results 3. Demonstrate discussion with children / parents regarding mucositis and care including care at home RCH Nursing Competency Workbook Chapter 3 Page 17

21 Nutrition (Parenteral) ALERT: The CVAD management competency should be completed in conjunction with this competency Competency tatement: The nurse safely and effectively administers Parenteral Nutrition RCH References: RCH Clinical Practice Guideline Nursing: Parenteral Nutrition Element Exemptions: oala and Cancer Care Unit (6a-b and 2b) 1. Locate and read the references related to this competency 2. tate the general indications for use of PN 3. Identify members of the multidisciplinary team involved in the care of this patient group, including each member s role 4. Identify at least five components which can be found in the PN solution 5. tate the ideal IV access for patients receiving a. Low dextrose nutrient solutions b. High dextrose nutrient solutions 6. Discuss the differences between hospital PN & Baxter PN for the following a. Fluid prescription and documentation b. Preparation & administration 7. Discuss the ongoing care requirements and management of patients receiving PN a. commencing b. ceasing c. weaning d. frequency of monitoring: i. Bloods ii. Urine iii. Weight iv. CVAD v. Documentation 8. Discuss how to administer non-compatible IV antibiotics to a patient receiving high dextrose PN solution 9. Discuss the correct action to be taken in the event that the nutrient solution finishes prior to the next bag being delivered from pharmacy 13.tate the maximum amount of potassium to be placed in a PN bag 1. Demonstrate checking of IV medication compatibility with PN prior to medication administration 2. Demonstrate IV line assembly & priming for the patient receiving a. Hospital PN olution b. Baxter PN olution 3. Demonstrate programming of IV pumps for all stages of weaning on & off PN RCH Nursing Competency Workbook Chapter 3 Page 18

22 Pain (Analgesia Infusion) Competency tatement: The nurse will safely and effectively administer analgesia infusions RCH References: RCH Intranet Anaesthesia & Pain Management Pain Management Guidelines: Opioid Infusion; etamine Infusion 1. Locate and read the references related to this competency 2. Describe the pharmacokinetics of the analgesia infusion 3. Discuss the potential side effects of analgesia infusions 4. tate the minimal clinical observations required for a patient receiving an analgesia infusion 5. Discuss reportable parameters 6. Discuss nursing actions to take if pain escalates 7. Discuss when to give analgesia boluses and when to increase analgesia infusions 8. tate when, why and how much naloxone should be given for opioid induced puritus, sedation and respiratory depression 9. Locate and complete the opioid primary competency quiz 1. Demonstrate pain assessment with an understanding of child development, language and appropriate pain assessment tools 2. Demonstrate accurate documentation of observations and assessment 3. Demonstrate correct set up of analgesia infusion pumps 4. Demonstrate explanation, answering questions and confirmation of understanding with family RCH Nursing Competency Workbook Chapter 3 Page 19

23 Pain (Patient Controlled Analgesia) Competency tatement: The nurse will safely and effectively administer patient controlled analgesia (PCA) RCH References: RCH Intranet Anaesthesia & Pain Management Pain Management Guidelines: Patient Controlled Analgesia 1. Locate and read the RCH Patient Controlled Analgesia Guidelines 2. Describe the pharmacokinetics of the opioid analgesia used 3. Discuss the potential side effects of PCA 4. Describe the PCA pump program and demonstrates where the prescribed program is documented 5. tate the minimum observations for a patient receiving a PCA and recognizes reportable parameters 6. Discuss the nursing actions to take if pain escalates 7. Explain when, why and how much naloxone should be given for opioid induced puritus, sedation and respiratory depression 8. Discuss how to transition from a PCA to oral analgesia 9. Locate and complete the PCA primary competency quiz 1. Demonstrate a pain assessment 2. Demonstrate accurate documentation of PCA use 3. Demonstrate explanation, answering of questions and confirmation of understanding with family RCH Nursing Competency Workbook Chapter 3 Page 20

24 Potassium Infusion (oncology) Competency tatement: The nurse can safely and effectively administer a potassium infusion in children with cancer RCH References: RCH Intranet Pharmacy medicines information: potassium chloride infusions 1. Locate and read the references related to this competency 2. Describe the function of Potassium in the body 3. Identify risk factors for low or high potassium levels in children with cancer 4. Describe the signs and symptoms of hypo / hyperkalaemia 5. Explain why children with cancer require Potassium corrections 6. Explain monitoring of potassium levels for acute corrections and ongoing infusions 7. Discuss the management if a patient s potassium is too high / low 8. Discuss the monitoring requirements for a patient receiving a potassium infusion 9. tate the concentration of a potassium infusion administered in the Cancer Care Unit 10. Discuss precautions when patient is receiving 60mmol/l CL in their intravenous fluids 1. Demonstrate preparation of a concentrated potassium infusion for acute corrections and ongoing infusions 2. Demonstrate accurate documentation of a potassium infusion RCH Nursing Competency Workbook Chapter 3 Page 21

25 Procedural edation nitrous oxide accreditation skill ALERT: This competency should follow the procedural sedation nitrous oxide accreditation theory competency. Nurses must attain the competency elements INDEPENDENTLY in order to be considered competent Competency statement: The nurse assesses and prepares a child and family for a procedure and safely and effectively administers nitrous oxide throughout the procedure. 1. tate when a sedation period starts and ends 2. Describe the function of the Nitrous Oxide delivery unit components. 3. Assemble the disposable equipment required for nitrous oxide administration 4. tate the two built in safety features on the nitrous unit and rationale for these 5. ummarise and demonstrate delivery of oxygen post sedation 6. Demonstrate a safety check of the nitrous oxide and emergency equipment prior to the start of the procedure 7. Demonstrate preparation of the child and parent for the sedation event 8. Integrate non pharmacological strategies as part of sedation event 9. Maintain line of sight throughout the sedation episode 10. Deliver nitrous oxide including making adjustment to: a. the nitrous oxide concentration based on anxiety, pain and sedation requirements b. the gas flows based on patients needs. 11. cavenge nitrous oxide gas in accordance with Occupation Health and afety tandards 12. Perform end of sedation period assessment including assessment of level of alertness and return to baselines vital signs. 13. Correctly document (MR 56) the sedation event including all baseline observations, risk assessments, sedation summary and discharge criteria 14. Demonstrate discussion of post sedation care including falls prevention with family and child RCH Nursing Competency Workbook Chapter 3 Page 22

26 Procedural edation nitrous oxide theory ALERT: This competency should precede the procedural sedation nitrous oxide competency skill. Completion of this competency in isolation does not indicate the nurse s competency to administer nitrous oxide Competency statement: The nurse has the requisite knowledge to assess and prepare a child and family for, nitrous oxide sedation and the safe delivery of nitrous oxide during a procedure RCH references: RCH Clinical Guidelines: Procedural Pain, edation - Procedural edation Guideline - Ward and Ambulatory Areas 1. Locate and read the references related to this competency 2. Complete online learning package and pre test 3. Discuss the role and responsibility of the sedater for a nitrous oxide sedation event including reporting of adverse event. 4. Describe pharmacological effects of nitrous oxide 5. Outline the differences between anaesthetic and procedural fasting guidelines and consent. 6. tate the three RCH services available to provide procedural sedation advice/consultation. 7. Describe five ways to prepare a child/family for a nitrous oxide sedation event 8. tate any specific variation to nitrous oxide sedation guideline that applies to your area 9. Describe what considerations should be taken when administering nitrous oxide with another primary sedation agent. 10. tate the rationale for a. Risk assessment b. Baseline observations and ongoing observations c. edation scale d. Line of sight monitoring e. Post sedation discharge criteria for patients in your area f. Falls prevention g. Emergency equipment h. Occupational Health and afety i. Nitrous oxide storage j. Documentation responsibilities 11. tate the action required for a. Equipment faults b. Loss of nitrous or oxygen gas flow c. Failure to sedate 12. Describe the adverse events that might occur during administration of nitrous oxide and outline the actions required 13. Describe the actions required for the following side effects: a. Hallucinations b. Over sedation c. Vomiting 14. tate the location of the emergency equipment unit/ department box. Not Applicable RCH Nursing Competency Workbook Chapter 3 Page 23

27 ubcutaneous Catheter devices management (Infusion and BD at-t-intima ) ALERT: For palliative care patients please refer to the symptom management plan as documented by the Victorian Paediatric Palliative Care Program Competency tatement: The nurse safely and effectively cares for a patient who requires the use of a ubcutaneous Catheter device RCH References: RCH Intranet Palliative Care For Health Professionals: Parenteral infusions and syringe drivers; RCH Policies & Procedures: Medication Management; RCH Clinical Practice Guidelines: ubcutaneous Catheter devices management Infusion and BD at-t-intima ; ucrose (oral) for procedural pain management in infants 1. Locate and read the references related to this competency 2. Discuss the indications for medications to be given subcutaneously 3. Outline and discuss the different anatomical positions that an Insuflon and BD af-t- Intima TM can be placed subcutaneously. Include; a. Appropriate insertion sites b. Areas to avoid c. Other considerations 4. Outline the management of a ubcutaneous Catheter device. Include; a. Ongoing assessment of an Insuflon and BD af-t-intima insitu (or insertion site) b. Length of insertion time and indications for resiting c. Potential complications and management 5. Outline the documentation required for management of the ubcutaneous Catheter device 6. Demonstrate discussion and education with the child and parents/caregivers regarding the ubcutaneous Catheter device and care at home 1. Demonstrate the procedure for the subcutaneous insertion of an Insuflon 2. Demonstrate the procedure for the subcutaneous insertion of a BD af-t-intima TM 3. Demonstrate the procedure for the administration of medications via an Insuflon 4. Demonstrate the procedure for the administration of a bolus/breakthrough dose of medication via a subcutaneous BD af-t-intima TM 5. Demonstrate the procedure for the administration of a continuous infusion via a subcutaneous BD af-t-intima TM 6. Demonstrate the procedure for the removal of an Insuflon 7. Demonstrate the procedure for the removal of a subcutaneous BD af-t-intima TM RCH Nursing Competency Workbook Chapter 3 Page 24

28 Competency Feedback & Reflection This section is used to document constructive feedback relating to specific elements of any competency from assessors, and also provides space to document reflection on your own practice (either in direct relation to the feedback, or separately). Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] RCH Nursing Competency Workbook Chapter 3 Page 25

29 Competency Feedback & Reflection This section is used to document constructive feedback relating to specific elements of any competency from assessors, and also provides space to document reflection on your own practice (either in direct relation to the feedback, or separately). Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] RCH Nursing Competency Workbook Chapter 3 Page 26

30 Competency Feedback & Reflection This section is used to document constructive feedback relating to specific elements of any competency from assessors, and also provides space to document reflection on your own practice (either in direct relation to the feedback, or separately). Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] RCH Nursing Competency Workbook Chapter 3 Page 27

31 Competency Feedback & Reflection This section is used to document constructive feedback relating to specific elements of any competency from assessors, and also provides space to document reflection on your own practice (either in direct relation to the feedback, or separately). Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] RCH Nursing Competency Workbook Chapter 3 Page 28

32 Competency Feedback & Reflection This section is used to document constructive feedback relating to specific elements of any competency from assessors, and also provides space to document reflection on your own practice (either in direct relation to the feedback, or separately). Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] Competency Name: Element(s): Assessor Feedback: elf-reflection: Assessor [sign and date] Nurse [sign and date] RCH Nursing Competency Workbook Chapter 3 Page 29

Cytotoxic and Biotherapies Credentialing Programme Module 6

Cytotoxic and Biotherapies Credentialing Programme Module 6 Cytotoxic and Biotherapies Credentialing Programme Module 6 1. Safe Handling and Administration of Cytotoxic and Biotherapies 2. Waste and Spill Management At the completion of this module the RN will

More information

Policies & Procedures. ID Number: 1118

Policies & Procedures. ID Number: 1118 Policies & Procedures Title: INTRAVENOUS AND/OR PERIPHERAL SALINE LOCK INSERTION AND MAINTENANCE ID Number: 1118 Authorization [X] SHR Nursing Practice Committee Source: Nursing Date Revised: September

More information

Medications or therapeutic solutions may be injected directly into the bloodstream

Medications or therapeutic solutions may be injected directly into the bloodstream Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals

More information

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION REGULATIONS RELATING TO ADMINISTRATION OF INTRAVENOUS THERAPY BY LICENSED NURSES

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION REGULATIONS RELATING TO ADMINISTRATION OF INTRAVENOUS THERAPY BY LICENSED NURSES 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 380 BOARD OF NURSING Chapter 10: REGULATIONS RELATING TO ADMINISTRATION OF INTRAVENOUS THERAPY BY LICENSED NURSES SUMMARY: This chapter identifies

More information

Cytotoxic and Biotherapies Credentialing Programme Module 5

Cytotoxic and Biotherapies Credentialing Programme Module 5 Cytotoxic and Biotherapies Credentialing Programme Module 5 1. Drug Dose Determination 2. Drug Calculations 3. Role of the Second Checker 4. The Checking Process At the completion of this module the RN

More information

CUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS

CUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS CUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS LEVELS I through IV A. OVERRIDING CRITICAL ELEMENTS Violation of an overriding area will result in termination and failure of the particular

More information

Administration of Medications & Fluids via a Peripheral Intravenous Cannula

Administration of Medications & Fluids via a Peripheral Intravenous Cannula Administration of Medications & Fluids via a Peripheral Intravenous Cannula Clinical S.O.P. No.: 22.0 Compiled by: Approved by: Review date: November 2016 Administration of Medications & Fluids via S.O.P.

More information

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS SUBCUTANEOUS THERAPY A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS PARTS I. Purposes II. General Information III. Responsibilities IV.

More information

Roles and Responsibilities Policy

Roles and Responsibilities Policy Roles and Responsibilities Policy Contents Policy... 2 Scope/Audience... 2 Associated Documents... 2 Definitions... 2 Accountability... 2 Scope of Practice Statement:... 2 Anaesthetic Technicians... 3

More information

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION This booklet was designed to help you and the important people in your life understand the treatment of high dose chemotherapy with stem cell support: a procedure

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They

More information

Cancer services children s CSCF v3.2

Cancer services children s CSCF v3.2 Cancer services children s CSCF v3.2 Module overview Please note: This module should be read in conjunction with the Fundamentals of the Framework (including glossary and acronym list), Children s Services

More information

Intravenous Therapy Principles of Care. Breege Smithers Practice Educator

Intravenous Therapy Principles of Care. Breege Smithers Practice Educator Intravenous Therapy Principles of Care Breege Smithers Practice Educator Objectives State indications for intravenous therapy List the advantages and disadvantages of intravenous therapy Identify the principles

More information

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND Monitor patient on the ward to detect trends in vital signs and to manage accordingly To recognise deteriorating trends and request relevant medical/out

More information

Accepted at Steering Group meeting 1 st July, 2011. Implementation date: September 2011 Review Date: May 2012

Accepted at Steering Group meeting 1 st July, 2011. Implementation date: September 2011 Review Date: May 2012 Intravenous BSc Student Nurse Competency Policy for BSc General and Integrated Nursing Students of Catherine McAuley School of Nursing and Midwifery and associated Health Service Providers. Accepted at

More information

Peripherally Inserted Central Catheter (PICC) for Outpatient

Peripherally Inserted Central Catheter (PICC) for Outpatient Peripherally Inserted Central Catheter (PICC) for Outpatient Introduction A Peripherally Inserted Central Catheter, or PICC line, is a thin, long, soft plastic tube inserted into a vein of the arm. It

More information

Epidural Management. Policy/Purpose. Scope

Epidural Management. Policy/Purpose. Scope Fluid & Medications Management Policy/Purpose... 1 Scope... 1 Associated documents... 2 General... 2 Epidural Indications... 2 Contra-indications:... 2 Educational requirements... 3 Procedural Considerations...

More information

Electronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with)

Electronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with) Diabetes Management for Children and Young People undergoing Surgery (0-16 yrs) Clinical Guideline Register No: 10096 Status: Public Developed in response to: Updated national guidelines Contributes to

More information

Guy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Central venous catheter: Peripherally inserted central catheter

Guy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Central venous catheter: Peripherally inserted central catheter Guy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Central venous catheter: Peripherally inserted central catheter This information leaflet aims to help answer some of the questions

More information

1.4.4 Oxyhemoglobin desaturation

1.4.4 Oxyhemoglobin desaturation Critical Care Therapy and Respiratory Care Section Category: Clinical Section: Clinical Monitoring Title: Monitoring of Patients Undergoing Conscious Sedation Policy #: 09 Revised: 05/00 1.0 DESCRIPTION

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information

Guideline for the use of subcutaneous hydration in palliative care (hypodermoclysis)

Guideline for the use of subcutaneous hydration in palliative care (hypodermoclysis) Guideline for the use of subcutaneous hydration in palliative care (hypodermoclysis) Date Approved by Network Governance September 2012 Date for Review September 2015 Page 1 of 7 1 Scope of Guideline 1.1

More information

Breast Pathway Group FEC 60 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer in Elderly / Frail

Breast Pathway Group FEC 60 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer in Elderly / Frail Breast Pathway Group FEC 60 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer in Elderly / Frail Indication: Neoadjuvant or adjuvant therapy for elderly and frail patients with breast

More information

ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS

ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS SASKATOON DISTRICT HEALTH Department of Nursing Affairs ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS SPECIAL NURSING PROCEDURE LEARNING PACKAGE This package provides the basic information necessary

More information

V: Infusion Therapy. Alberta Licensed Practical Nurses Competency Profile 217

V: Infusion Therapy. Alberta Licensed Practical Nurses Competency Profile 217 V: Infusion Therapy Alberta Licensed Practical Nurses Competency Profile 217 Competency: V-1 Knowledge of Intravenous Therapy V-1-1 V-1-2 V-1-3 V-1-4 V-1-5 Demonstrate knowledge and ability to apply critical

More information

Guidelines for the Use of Naloxone in Palliative Care in Adult Patients

Guidelines for the Use of Naloxone in Palliative Care in Adult Patients Guidelines for the Use of Naloxone in Palliative Care in Adult Patients Date Approved by Network Governance May 2012 Date for Review May 2015 Changes between Version 1 and 2 1. Guideline background 2.

More information

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline

More information

Cyclophosphamide treatment and stem cell collection. Bone Marrow Transplant Unit Information for patients

Cyclophosphamide treatment and stem cell collection. Bone Marrow Transplant Unit Information for patients Cyclophosphamide treatment and stem cell collection Bone Marrow Transplant Unit Information for patients i Important dates Outpatient appointment for counselling and consent. Date for day case appointment

More information

PROCEDURE FOR SUBCUTANEOUS INSERTION, REMOVAL, MEDICATION ADMINISTRATION AND FLUID ADMINISTRATION FOR COMMUNITY PALLIATIVE CARE PATIENTS

PROCEDURE FOR SUBCUTANEOUS INSERTION, REMOVAL, MEDICATION ADMINISTRATION AND FLUID ADMINISTRATION FOR COMMUNITY PALLIATIVE CARE PATIENTS PROCEDURE FOR SUBCUTANEOUS INSERTION, REMOVAL, MEDICATION ADMINISTRATION AND FLUID ADMINISTRATION FOR COMMUNITY PALLIATIVE CARE PATIENTS Approved: February 2010 Date for review: February 2010 1 PROCEDURE

More information

POAC CLINICAL GUIDELINE

POAC CLINICAL GUIDELINE POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal

More information

Guideline for the Safe Handling and Administration of Subcutaneous Cyotoxic Chemotherapy for Adults in the Community Setting

Guideline for the Safe Handling and Administration of Subcutaneous Cyotoxic Chemotherapy for Adults in the Community Setting Guideline for the Safe Handling and Administration of Subcutaneous Cyotoxic Chemotherapy for Adults in the Community Setting Guideline for the Safe Handling and Administration of Subcutaneous Cyotoxic

More information

Central Venous Catheter Care For Haemodialysis

Central Venous Catheter Care For Haemodialysis Central Venous Catheter Care For Haemodialysis Information For Parents and Carers Haemodialysis Unit 01 878 4757 Main Hospital Number 01 878 4200 Central Venous Catheters We hope this booklet will help

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: infusion_therapy_in_the_home 3/1998 2/2016 2/2017 2/2016 Description of Procedure or Service Home infusion

More information

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood

More information

Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol

Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol Who Division 1 Registered Nursing staff for the purposes of administering and monitoring of infusion Division 2

More information

Student Nurse/Midwife Responsibilities with Fluid and Medication Management

Student Nurse/Midwife Responsibilities with Fluid and Medication Management All staff using the Fluid & Medication Management policies must first familiarise themselves with the contents of: Roles & Responsibilities Policy, Basic Infection Prevention & Control Principles related

More information

How To Safely Infuse Aupbsc

How To Safely Infuse Aupbsc The Process of Infusing Cryopreserved Stem Cells by Registered Nurses Presenters: Kristen Brazel, RN BScN Kate Duke, RN BScN 5 West Haematology Unit, The Ottawa General Hospital, Ottawa, Ontario, Canada

More information

MULTI AGENCY POLICY FOR THE ADMINISTRATION OF MEDICATION AND HEALTH CARE PROCEDURES:

MULTI AGENCY POLICY FOR THE ADMINISTRATION OF MEDICATION AND HEALTH CARE PROCEDURES: MULTI AGENCY POLICY FOR THE ADMINISTRATION OF MEDICATION AND HEALTH CARE PROCEDURES: Early years provision, Educational Establishments and Voluntary Services Document reference number: C O R P O L O 0

More information

Procedure for Inotrope Administration in the home

Procedure for Inotrope Administration in the home Procedure for Inotrope Administration in the home Purpose This purpose of this procedure is to define the care used when administering inotropic agents intravenously in the home This includes: A. Practice

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Goal 1 Nursing are enter ccreditation Program Improve the accuracy of patient and resident identification. NPSG.01.01.01 Use at least two patient or resident identifiers when

More information

Collaboration Anesthesia

Collaboration Anesthesia HPC hpcconnection.ca Nursing Neuro - axial Analgesia cross sector Pharmacists Intractable patient centered Opioids Interventional Consensus Collaboration Anesthesia Physicians epidural evidence based Intraspinal

More information

A PROCEDURAL GUIDE TO MIDLINE CATHETER INSERTION

A PROCEDURAL GUIDE TO MIDLINE CATHETER INSERTION A PROCEDURAL GUIDE TO MIDLINE CATHETER INSERTION See Also CPG midline catheters for indications, contraindications and post insertion management What is a midline A midline catheter is an 8-12 cm catheter

More information

Radioactive Ra 223 therapy. Information for patients Weston Park Hospital

Radioactive Ra 223 therapy. Information for patients Weston Park Hospital Radioactive Ra 223 therapy Information for patients Weston Park Hospital page 2 of 8 This leaflet contains information about radioactive Ra 223 therapy. If you have any questions about your treatment,

More information

Guidance on competencies for management of Cancer Pain in adults

Guidance on competencies for management of Cancer Pain in adults Guidance on competencies for management of Cancer Pain in adults Endorsed by: Contents Introduction A: Core competencies for practitioners in Pain Medicine B: Competencies for practitioners in Pain Medicine

More information

Administering Medications

Administering Medications Administering Medications Pharmacology for Healthcare Professionals seventh edition Donna F. Gauwitz, R.N., Nursing Consultant Senior Teaching Specialist of Nursing University of Minnesota Minnesota and

More information

Lung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC)

Lung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC) Indication: NICE TA181 First line treatment option in advanced or metastatic non-squamous NSCLC (histology confirmed as adenocarcinoma or large cell carcinoma) Performance status 0-1 Regimen details: Pemetrexed

More information

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) Types of Catheter Related Thrombotic A catheter-related thrombus may be intraluminal (inside the catheter)

More information

Before your child has a stem cell transplant (SCT)

Before your child has a stem cell transplant (SCT) Before your child has a stem cell transplant (SCT) A guide for families The information contained within this leaflet is the property of Imperial College London Healthcare NHS Trust. Introduction This

More information

Information for people being discharged with a naso-gastric (NG) feeding tube

Information for people being discharged with a naso-gastric (NG) feeding tube Information for people being discharged with a naso-gastric (NG) feeding tube The aim of this leaflet is to provide patients with the relevant information for the use of a nasogastric tube. It will include:

More information

MISSISSIPPI BOARD OF NURSING IV THERAPY COURSE FOR THE EXPANDED ROLE LICENSED PRACTICAL NURSE COURSE OUTLINE

MISSISSIPPI BOARD OF NURSING IV THERAPY COURSE FOR THE EXPANDED ROLE LICENSED PRACTICAL NURSE COURSE OUTLINE THEORY MINIMUM 40 HOURS COURSE OUTLINE UNIT TOPIC HOURS* I LEGAL ASPECTS AND PRACTICE OF IV THERAPY 1 II REVIEW OF ANATOMY AND PHYSIOLOGY 6 III FLUID AND ELECTROLYTE BALANCE 10 IV EQUIPMENT AND PROCEDURES

More information

S9 Administer thrombolytic treatment in acute ischaemic stroke

S9 Administer thrombolytic treatment in acute ischaemic stroke S9 Administer thrombolytic treatment in acute ischaemic Screening and initiating treatment, overseeing competency of treatment About this workforce competence This competence is about the emergency administration

More information

POSSIBLE NURSING DIAGNOSIS: Pain Potential for Infection / Infection Fluid volume deficit

POSSIBLE NURSING DIAGNOSIS: Pain Potential for Infection / Infection Fluid volume deficit 1 Procedure for Subcutaneous Over-the-needle Cannula Insertion, Removal, Medication Administration, and Fluid Administration for the Individual in the Home PURPOSE: To provide medication via the subcutaneous

More information

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins)

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) I HEAR YA KNOCKING BUT YOU CAN T COME IN (electrolytes) TAKE MY BREATH AWAY (Opiates-morphine) OUT WITH

More information

Introduction. Definition

Introduction. Definition DIRECTIVES FOR PRIVATE AMBULATORY SURGICAL CENTRES PROVIDING AMBULATORY SURGERY: REGULATION 4(1) OF THE PRIVATE HOSPITALS AND MEDICAL CLINICS REGULATIONS [CAP 248, Rg 1] I Introduction 1 These directives

More information

Best practice in the management of epidural analgesia in the hospital setting

Best practice in the management of epidural analgesia in the hospital setting Best practice in the management of epidural analgesia in the hospital setting FACULTY OF PAIN MEDICINE of The Royal College of Anaesthetists Royal College of Anaesthetists Royal College of Nursing Association

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Effective January 1, 2015 Goal 1 Improve the accuracy of resident identification. NPSG.01.01.01 Long Term are ccreditation Program Medicare/Medicaid ertification-based Option

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological therapies can suppress the ability of the bone

More information

GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS

GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS 5 th Edition November 2015 NHS Pharmaceutical Quality Assurance Committee 2015 British Oncology Pharmacists Association Pharmaceutical

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Sedation for diagnostic and therapeutic procedures in children and young people 1.1 Short title Sedation in children and young

More information

Note that the following document is copyright, details of which are provided on the next page.

Note that the following document is copyright, details of which are provided on the next page. Please note that the following document was created by the former Australian Council for Safety and Quality in Health Care. The former Council ceased its activities on 31 December 2005 and the Australian

More information

Australian and New Zealand College of Anaesthetists (ANZCA) Guidelines for the Management of Major Regional Analgesia

Australian and New Zealand College of Anaesthetists (ANZCA) Guidelines for the Management of Major Regional Analgesia PS03 2014 Australian and New Zealand College of Anaesthetists (ANZCA) Faculty of Pain Medicine Guidelines for the Management of Major Regional Analgesia 1. OVERVIEW This document is intended to apply to

More information

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride A leaflet will be included in each pack. The leaflet will consist of a Technical Information Leaflet and a Patient Information Leaflet. The two leaflets will be easily separatable. The text of the Technical

More information

V: Infusion Therapy. College of Licensed Practical Nurses of Alberta, Competency Profile for LPNs, 3rd Ed. 181

V: Infusion Therapy. College of Licensed Practical Nurses of Alberta, Competency Profile for LPNs, 3rd Ed. 181 V: Infusion Therapy College of Licensed Practical Nurses of Alberta, Competency Profile for LPNs, 3rd Ed. 181 Competency: V-1 Principles of V-1-1 V-1-2 V-1-3 V-1-4 V-1-5 Demonstrate knowledge and ability

More information

NURSING 500.105 Effective Date Title: 6/12 SCOPE OF PRACTICE FOR STUDENT NURSES AND NURSING ASSISTANTS

NURSING 500.105 Effective Date Title: 6/12 SCOPE OF PRACTICE FOR STUDENT NURSES AND NURSING ASSISTANTS XXX DAYTONA XXX _OCEANSIDE HEALTH CARE PARTNERS Department: Page 1 of 5 POLICY & PROCEDURE Policy Number NURSING 500.105 Effective Date Title: 6/12 SCOPE OF PRACTICE FOR STUDENT NURSES AND NURSING ASSISTANTS

More information

Clinical Guideline For The Use of Rectus Sheath Catheters For The Management of Pain Following Laparotomy. 1. Aim/Purpose of this Guideline

Clinical Guideline For The Use of Rectus Sheath Catheters For The Management of Pain Following Laparotomy. 1. Aim/Purpose of this Guideline Clinical Guideline For The Use of Rectus Sheath Catheters For The Management of Pain Following Laparotomy. 1. Aim/Purpose of this Guideline 1.1. Nursing guidelines for the use of rectus sheath catheters

More information

Other treatments for chronic myeloid leukaemia

Other treatments for chronic myeloid leukaemia Other treatments for chronic myeloid leukaemia This information is an extract from the booklet Understanding chronic myeloid leukaemia. You may find the full booklet helpful. We can send you a copy free

More information

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients The Regimen contains: V = vincristine (Oncovin ) A = Adriamycin (doxorubicin) D = Decadron (dexamethasone) How Is This Regimen Given?

More information

DISTRIBUTION: All Clinical Units JHCH, J1, J2, H1, Oncology Day Stay Unit & J2 Day Stay Unit. JHH Intensive Care Unit and Emergency Department

DISTRIBUTION: All Clinical Units JHCH, J1, J2, H1, Oncology Day Stay Unit & J2 Day Stay Unit. JHH Intensive Care Unit and Emergency Department 13.12 PROCEDURE SUBJECT: (This guideline is relevant to inpatient use only) DOCUMENT NUMBER: 13.12 DATE DEVELOPED: May 2013 LAST REVISED DATE: NEW PLANNED REVIEW DATE: November 2017 DISTRIBUTION: All Clinical

More information

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP)

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) Protocol Code Tumour Group Contact Physician UGUTIP Genitourinary Dr.

More information

*Reflex withdrawal from a painful stimulus is NOT considered a purposeful response.

*Reflex withdrawal from a painful stimulus is NOT considered a purposeful response. Analgesia and Moderate Sedation This Nebraska Board of Nursing advisory opinion is issued in accordance with Nebraska Revised Statute (NRS) 71-1,132.11(2). As such, this advisory opinion is for informational

More information

Insertion of a Central Catheter (Hickman/Groshong Catheter)

Insertion of a Central Catheter (Hickman/Groshong Catheter) Insertion of a Central Catheter (Hickman/Groshong Catheter) Patient Information Introduction This booklet has been written to provide information to patients about to have a central catheter inserted in

More information

Insulin Pump Therapy during Pregnancy and Birth

Insulin Pump Therapy during Pregnancy and Birth Approvals: Specialist Group: Miss F Ashworth, Dr I Gallen, Dr J Ahmed Maternity Guidelines Group: V1 Dec 2012 Directorate Board: V1 Jan 2013 Clinical Guidelines Subgroup: July 2011 MSLC: V1 Nov 2012 Equality

More information

Cyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft

Cyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft INDICATIONS Cyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft Aplastic Anaemia (patients under 40 years) PRE-ASSESSMENT Ensure pre-transplant work-up form is complete Ensure patient has triple

More information

Epidural Continuous Infusion. Patient information Leaflet

Epidural Continuous Infusion. Patient information Leaflet Epidural Continuous Infusion Patient information Leaflet April 2015 Introduction You may already know that epidural s are often used to treat pain during childbirth. This same technique can also used as

More information

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer )

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) Departments of Haematology, Nephrology and Pharmacy Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) [Care Pathway Review Date] Guidance for use This Care Pathway is intended

More information

Safe Handling of Cytotoxic Materials

Safe Handling of Cytotoxic Materials Safe Handling of Cytotoxic Materials Kara Henman RN, MN, CON(C) Oncology Practice Consultant Cancer Care Nova Scotia What are hazardous drugs? Chemotherapy Immunosuppressive agents Biological agents Antiviral

More information

Management of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday)

Management of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday) Title: Author: Speciality / Division: Directorate: CLINICAL GUIDELINES ID TAG Management of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday) Dr Teresa Mulroe and Dr Sarinda

More information

Use of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013)

Use of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013) Use of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013) Introduction The IntraVENOUS medicines section of the Injectable Medicines Guide website

More information

CH CONSCIOUS SEDATION

CH CONSCIOUS SEDATION Summary: CH CONSCIOUS SEDATION It is the policy of Carondelet Health that moderate conscious sedation of patients will be undertaken with appropriate evaluation and monitoring. Effective Date: 9/4/04 Revision

More information

Intraosseous Vascular Access and Lidocaine

Intraosseous Vascular Access and Lidocaine Intraosseous Vascular Access and Lidocaine Intraosseous (IO) needles provide access to the medullary cavity of a bone. It is a technique primarily used in emergency situations to administer fluid and medication

More information

BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY

BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY 1 BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY GUIDELINES ON ADMINISTRATION OF INTRAVENOUS IRON SUCROSE (VENOFER) AS A BOLUS DOSE IN THE RENAL OUTPATIENT SETTING Date Developed: August- October 2007 RENAL

More information

Policy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters

Policy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters Policy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters Purpose: Blood Withdrawal: To obtain blood samples for laboratory evaluation, eliminating

More information

JOB DESCRIPTION. In conjunction with the Senior Charge Nurse to provide clear and consistent leadership to a team of nurses.

JOB DESCRIPTION. In conjunction with the Senior Charge Nurse to provide clear and consistent leadership to a team of nurses. JOB DESCRIPTION 1. JOB IDENTIFICATION Job Title: Charge Nurse Band 6 Responsible to (insert job title): Directorate: Operating Division: Senior Charge Nurse Emergency Care Directorate Fife Acute Hospitals

More information

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient

More information

Status: Standard Procedure: specifies the procedures to be followed, only in exceptional circumstances should these not be followed

Status: Standard Procedure: specifies the procedures to be followed, only in exceptional circumstances should these not be followed Page 1 of 6 Status: Standard Procedure: specifies the procedures to be followed, only in exceptional circumstances should these not be followed Title: Standard Procedure for the Irrigating (flushing) of

More information

SAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010

SAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010 SAFE HANDLING OF HAZARDOUS MEDICATIONS Cytotoxic and Non-Cytotoxic Winnipeg Regional Health Authority Policy # 110.160.010 By the end of this presentation staff should be able to 1. Understand what information

More information

Delivering nutrition, fluids & medication via a PEG. By Julia Pointer & Caroline Ross, Staff Nurses, Hospice Day Service

Delivering nutrition, fluids & medication via a PEG. By Julia Pointer & Caroline Ross, Staff Nurses, Hospice Day Service Delivering nutrition, fluids & medication via a PEG By Julia Pointer & Caroline Ross, Staff Nurses, Hospice Day Service Aims of this session? To give an explanation of the theory and practice of a Percutaneous

More information

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation

More information

Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home

Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home Contents Page Important contact numbers 1 General information on preparing and administering IV antibiotics

More information

Vaxcel PICCs Valved and Non-Valved. A Patient s Guide

Vaxcel PICCs Valved and Non-Valved. A Patient s Guide Vaxcel PICCs Valved and Non-Valved A Patient s Guide Information about your Vaxcel PICC is available by calling the Navilyst Medical Vascular Access Information Line 800.513.6876 Vaxcel Peripherally Inserted

More information

XIV ANNUAL MEETING OF NURSING

XIV ANNUAL MEETING OF NURSING Archive of Oncology 2000;8(Suppl 1):69. SESSION 5 XIV ANNUAL MEETING OF NURSING 69 Archive of Oncology 2000;8(Suppl 1):70. 70 UDC: 616.34-007.272:616-089.8:614.39 I. GAJI M. ULAFI Æ. MIHAJLOVI R. NE I

More information

Chemotherapy Administration, Hydration and Therapeutic, Prophylactic, and Diagnostic Injections and Infusions

Chemotherapy Administration, Hydration and Therapeutic, Prophylactic, and Diagnostic Injections and Infusions Chemotherapy Administration, Hydration and Therapeutic, Prophylactic, and Diagnostic Injections and Infusions Table of Contents: Overview... Professional Services... 2 Services... 4 Overview Chemotherapy

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323

More information

Date effective: Jan 2005 Date revised: June 2015

Date effective: Jan 2005 Date revised: June 2015 Section H: Administration of Blood Products Page 1 of 8 I. Introduction... 1 II. Intravenous (IV) Access... 2 Peripheral Line:...2 Central Venous Catheter:...2 III. Compatible Solutions with Blood Products...

More information

PERIPHERAL INTRAVENOUS CATHETER MANAGEMENT Adult & Paed

PERIPHERAL INTRAVENOUS CATHETER MANAGEMENT Adult & Paed Auckland District BOARD Clinical Practice Health Board (Section 1) Manual Overview This Document This document covers recommended best practices relating to the selection, insertion, care and management

More information

Suturing Policy for Nurses in Emergency Departments

Suturing Policy for Nurses in Emergency Departments This is an official Northern Trust policy and should not be edited in any way Suturing Policy for Nurses in Emergency Departments Reference Number: NHSCT/12/545 Target audience: Registered Nurses Sources

More information

2015 -- S 0169 S T A T E O F R H O D E I S L A N D

2015 -- S 0169 S T A T E O F R H O D E I S L A N D ======== LC000 ======== 01 -- S 01 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO INSURANCE - ACCIDENT AND SICKNESS INSURANCE POLICIES Introduced

More information

JOB DESCRIPTION FORM. Location: FHP

JOB DESCRIPTION FORM. Location: FHP JOB DESCRIPTION FORM Job Title: Medical Assistant Location: FHP Job Summary: Reports directly to the Senior Specialty Services Manager and interviews patients to obtain medical information and measures

More information

VA SAN DIEGO HEALTHCARE SYSTEM MEMORANDUM 118-28 SAN DIEGO, CA

VA SAN DIEGO HEALTHCARE SYSTEM MEMORANDUM 118-28 SAN DIEGO, CA GUIDELINES FOR PATIENT-CONTROLLED ANALGESIA (PCA) AND PATIENT- CONTROLLED EPIDURAL ANALGESIA (PCEA) FOR ACUTE PAIN MANAGEMENT 1. PURPOSE: To assure the safe and effective use of patient controlled analgesia

More information